The SELECT trial (studying cardiovascular outcomes in people with obesity) found that the extent of weight loss from GLP-1 therapy did not correlate with the drug's effects in reducing heart attack, stroke, and cardiovascular death, indicating benefits independent of weight loss magnitude.

factualpending

Speaker

Unidentified Speaker — GLP-1 Aren’t Just Weight Loss Drugs: A Provocative Discovery [5nGTUaqKmcY]

Evidence Quote

“in the select cardiovascular outcomes trial studying people with obesity the extent of weight loss did not correlate with the effects of the drug to reduce heart attack stroke and cardiovascular death”

Source

GLP-1 Aren’t Just Weight Loss Drugs: A Provocative Discovery— Nick Norwitz MD PhD
Created: 8/11/2026, 6:37:12 AM

Your notes

Loading notes...